Are you navigating the complex world of pharmaceutical manufacturing? Choosing the right AstraZeneca supplier can feel daunting, but it’s crucial for your project’s success. With so many options in the USA, how do you find the best fit for your needs? In this article, we’ll explore the top AstraZeneca manufacturing locations, diving into what makes each factory stand out. From cutting-edge technology to quality assurance practices, the right choice can elevate your product and streamline your operations.
Imagine partnering with a manufacturer that not only meets your expectations but exceeds them. Ready to discover which locations can provide that competitive edge? Let’s dive in and find the perfect AstraZeneca factory for you!
Related Video
AstraZeneca in United States
Product Details:
AstraZeneca is a global, science-led biopharmaceutical business offering innovative medicines used by millions of patients worldwide.
Pros:
– Innovative medicines that address various health conditions.
– Global presence with significant research and development capabilities.
– Commitment to community impact and patient support.
Locations – AstraZeneca
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United …
Product Details:
AstraZeneca is investing $3.5 billion in research and development (R&D) and manufacturing in the United States.
Pros:
– Significant investment in R&D indicates a commitment to innovation.
– Enhancement of manufacturing capabilities in the U.S. can lead to increased
AstraZeneca invests $3.5B in US manufacturing, R&D
Product Details:
AstraZeneca is investing $3.5 billion in U.S. manufacturing, research, and development to enhance its production capabilities and support its pipeline of medicines.
Pros:
– Significant investment in U.S. manufacturing capabilities.
– Focus on research and development to support new medicines.
AstraZeneca investing $3.5bn in R & D and manufacturing in the US
Product Details:
AstraZeneca offers innovative life-changing medicines primarily in the fields of Oncology, BioPharmaceuticals, and Rare Disease.
Technical Parameters:
– Multibillion dollar investment in R&D and manufacturing
– State-of-the-art R&D centre in Cambridge, Massachusetts
– Nextgen manufacturing facility for biologics in Maryland
– Cell therapy manufacturing capacity on both coasts of the US
Application Scenarios:
– Oncology treatments
– BioPharmaceuticals development
– Rare Disease therapies
– High-value clinical trials
Pros:
– Strong growth trajectory with a 21% increase in total revenue
– High demand for medicines across multiple therapeutic areas
– Recognition of scientific research at major oncology conferences
– Commitment to innovation and healthcare leadership in the US
Cons:
– Investigation by Chinese authorities regarding importation of cancer treatments
– Recent drop in UK share price due to executive investigations
AZ’s $300M cell therapy manufacturing site opens in Maryland
Product Details:
AstraZeneca has opened a $300 million cell therapy manufacturing facility in Maryland, focusing on the production of advanced therapies.
Technical Parameters:
– $300 million investment
– Cell therapy manufacturing
– Located in Maryland
Application Scenarios:
– Manufacturing of advanced cell therapies
– Support for clinical trials
– Commercial production of cell therapies
Pros:
– State-of-the-art manufacturing capabilities
– Increased production capacity for cell therapies
– Supports the growing demand for advanced therapies
AstraZeneca opens cell therapy manufacturing site in Rockville
Product Details:
AstraZeneca’s cell therapy manufacturing site in Rockville focuses on the production of advanced cell therapies for various medical applications.
Technical Parameters:
– State-of-the-art manufacturing facility
– Compliance with regulatory standards
– Advanced technology for cell processing
Application Scenarios:
– Treatment of cancer
– Regenerative medicine
– Personalized medicine
Pros:
– High-quality manufacturing processes
– Ability to scale production
– Innovative technology in cell therapy
Cons:
– High operational costs
– Complex regulatory environment
– Potential for production delays
AstraZeneca Opens $300 Million Cell Therapy Manufacturing Facility in …
Product Details:
CAR-T cell therapies—personalized treatments that are transforming how cancer is treated around the world.
Technical Parameters:
– 84,000-square-foot facility
– $300 million investment
– Part of a $3.5 billion national investment in research and manufacturing
Application Scenarios:
– Clinical trials for cancer treatments
– Commercial production of cell therapies
Pros:
– Transforms cancer treatment with personalized therapies
– Creates more than 150 high-quality jobs
– Strengthens Montgomery County’s bio-life sciences hub
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United …
Product Details:
AstraZeneca is expanding its research and manufacturing operations in the U.S. with a $3.5 billion investment, focusing on oncology, biopharmaceuticals, and rare diseases.
Technical Parameters:
– $3.5 billion total investment by 2026
– $2 billion in new investment for expansion
– Addition of over 1,000 jobs
– Expansion includes R&D and biologics manufacturing facilities
Application Scenarios:
– Development of cutting-edge therapies
– Manufacturing of biologics and cell therapies
– Research and development in oncology and rare diseases
Pros:
– Supports U.S. leadership in healthcare innovation
– Increased demand for medicines in oncology and rare diseases
– Projected revenue growth to $80 billion by 2030
Cons:
– Details on specific commercial properties not disclosed
– Market for life science space shows signs of slowing
AstraZeneca expands US manufacturing footprint to accelerate ambitions …
Product Details:
AstraZeneca is developing a portfolio of next-generation cell therapies, particularly focusing on T-cell therapies for cancer treatment.
Technical Parameters:
– Armoured autologous CAR-T therapies targeting specific antigens like Glypican 3
– T-cell receptor therapies (TCR-Ts) targeting mutations such as TP53 and KRAS
– Clinical trials in various phases, including Phase I for several therapies
Application Scenarios:
– Clinical trials for cancer treatment using T-cell therapies
– Potential future commercial supply of cell therapies
– Targeting solid tumors and overcoming immune-suppressive tumor microenvironments
Pros:
– Investment of $300 million to enhance manufacturing capabilities for critical
– Creation of over 150 highly skilled jobs in the local area
– Proximity to research centers and universities enhances talent acquisition
Comparison Table
| Company | Product Details | Pros | Cons | Website |
|---|---|---|---|---|
| AstraZeneca in United States | AstraZeneca is a global, science-led biopharmaceutical business offering | Innovative medicines that address various health conditions. Global presence | www.astrazeneca-us.com | |
| Locations – AstraZeneca | careers.astrazeneca.com | |||
| AstraZeneca invests $3.5 billion in R&D and manufacturing in the United … | AstraZeneca is investing $3.5 billion in research and development (R&D) and | Significant investment in R&D indicates a commitment to innovation. Enhancement | www.astrazeneca.com | |
| AstraZeneca invests $3.5B in US manufacturing, R&D | AstraZeneca is investing $3.5 billion in U.S. manufacturing, research, and | Significant investment in U.S. manufacturing capabilities. Focus on research | www.manufacturingdive.com | |
| AstraZeneca investing $3.5bn in R & D and manufacturing in the US | AstraZeneca offers innovative life-changing medicines primarily in the fields | Strong growth trajectory with a 21% increase in total revenue High demand for | Investigation by Chinese authorities regarding importation of cancer | www.businessweekly.co.uk |
| AZ’s $300M cell therapy manufacturing site opens in Maryland | AstraZeneca has opened a $300 million cell therapy manufacturing facility in | State-of-the-art manufacturing capabilities Increased production capacity for | www.fiercepharma.com | |
| AstraZeneca opens cell therapy manufacturing site in Rockville | AstraZeneca’s cell therapy manufacturing site in Rockville focuses on the | High-quality manufacturing processes Ability to scale production Innovative | High operational costs Complex regulatory environment Potential for production | bethesdamagazine.com |
| AstraZeneca Opens $300 Million Cell Therapy Manufacturing Facility in … | CAR-T cell therapies—personalized treatments that are transforming how cancer | Transforms cancer treatment with personalized therapies Creates more than 150 | www2.montgomerycountymd.gov | |
| AstraZeneca invests $3.5 billion in R&D and manufacturing in the United … | AstraZeneca is expanding its research and manufacturing operations in the U.S. | Supports U.S. leadership in healthcare innovation Increased demand for | Details on specific commercial properties not disclosed Market for life science | rockvilleredi.org |
| AstraZeneca expands US manufacturing footprint to accelerate ambitions … | AstraZeneca is developing a portfolio of next-generation cell therapies, | Investment of $300 million to enhance manufacturing capabilities for critical | www.astrazeneca-us.com |
Frequently Asked Questions (FAQs)
Where can I find AstraZeneca manufacturing locations in the USA?
You can find AstraZeneca manufacturing locations by visiting their official website, where they often list their facilities. Additionally, industry reports and databases may provide insights into their operational sites. Networking with industry professionals or attending pharmaceutical trade shows can also help you discover relevant manufacturing locations.
What should I consider when choosing a supplier for AstraZeneca products?
When selecting a supplier, consider their compliance with regulatory standards, quality assurance processes, and production capacity. It’s also important to evaluate their experience in handling AstraZeneca products and their reputation in the industry. Communication and reliability are key factors to ensure a smooth partnership.
Are there specific certifications I should look for in AstraZeneca manufacturers?
Yes, look for manufacturers that hold certifications such as Good Manufacturing Practices (GMP), ISO 9001, and any relevant FDA approvals. These certifications indicate that the manufacturer adheres to high-quality standards and regulatory requirements, ensuring the safety and efficacy of the products.
How can I assess the quality of AstraZeneca manufacturing facilities?
You can assess the quality by reviewing their compliance history, inspection reports, and customer testimonials. Visiting the facility, if possible, allows you to see their operations firsthand. Additionally, inquire about their quality control processes and any recent audits to gauge their commitment to maintaining high standards.
What are the common challenges in sourcing from AstraZeneca manufacturers?
Common challenges include navigating regulatory compliance, ensuring consistent product quality, and managing supply chain disruptions. Additionally, some manufacturers may have limited production capacity or longer lead times. It’s essential to communicate clearly and establish strong relationships to mitigate these challenges effectively.
